NEW YORK (360Dx) – Quest Diagnostics announced today the formation of the Global Diagnostics Network (GDN), a partnership with other large labs across the globe for the sharing of diagnostic innovation, information, and services.
The initial focus of the new partnership will include collaboration on companion diagnostics, and the creation of an emerging pathogen preparedness network to expedite infectious disease research and response. Additional initiatives are expected to be rolled out based on regional and global priorities.
Quest's partners in the new network include Al Borg Medical Laboratories, founded in Saudi Arabia, with labs across the Middle East and Africa; Dasa, based in Brazil; GC Labs, based in South Korea; KingMed Diagnostics, based in Hong Kong with labs across South East Asia; Primary Health Care, based in Australia; and SynLab, based in Germany with labs across Europe and on four continents.
Quest Chairman, President and CEO Steve Rusckowski said that the new network would enable fast, consistent access to diagnostic innovations and would facilitate the sharing of best practices.
"As we met with regional lab leaders over the past year, it became clear that we can accelerate the development and delivery of advanced diagnostics and diagnostic insight by bringing together our peers and sharing best practices," he said, in a statement.
Carrie Eglinton Manner, Quest's senior vice president, advanced diagnostics, said that the collaboration is also intended to help remove silos around knowledge and resources in different regions.